Preprint
Article

This version is not peer-reviewed.

Periosteum-Derived Osteo-Like Cells and Their Lyophilized Conditioned Medium Improve Bone Microarchitecture and Mineralized Tissue in Ovariectomized Rats: A Proof-of-Concept Study

Submitted:

28 September 2026

Posted:

29 September 2026

You are already at the latest version

Abstract
Periosteum-derived osteo-like cells (PDOCs) and their lyophilized conditioned medium are promising tools for bone regeneration, but their therapeutic potential for osteoporosis remains unknown. This study evaluated the effects of PDOCs and their lyophilized conditioned medium on bone mineralization and microarchitecture in ovariectomized rats. Eighteen ovariectomized rats (6 animals per group) received PBS (Negative Control Group–NCG); PDOCs (Periosteum Osteolike Cell Group - POCG), or PDOCs lyophilized conditioned medium (Periosteum Osteolike lyophilized conditioned medium Group - POCM). All animals were euthanized after 42 days, and the femurs submitted to microCT and histomorphometric analysis to determine: (1) thickness of the cortical bone; (2) number of trabeculae; (3) percentage of mineralized tissue; (4) percentage of collagen fibers; and (5) percentage of medullary spaces. The thickness of the cortical bone was statistically higher in POCG and POCM than in NCG animals (p<0.05). The trabecular number was higher in POCG and POCM than in NCG rats (p<0.05). The percentage of mineralized tissue was higher in POCG and POCM than in NCG animals (p<0.05), and no statistically significant difference was observed for collagen fibers and percentage of medullary spaces among groups. The use of PDOCs and their lyophilized conditioned medium improved cortical bone thickness, the number of trabeculae and the level of mineralized tissue, suggesting that tissue engineering approaches with PDOC and their lyophilized conditioned medium have potential use for the treatment of osteoporosis.
Keywords: 
;  ;  ;  ;  
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.